Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125635181 | 12563518 | 1 | I | 20160712 | 20160715 | 20160715 | EXP | CA-AMGEN-CANSP2016090908 | AMGEN | 0.00 | F | Y | 0.00000 | 20160715 | OT | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125635181 | 12563518 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | U | 103795 | UNKNOWN FORMULATION | ||||||||
125635181 | 12563518 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | UNK | 0 | ||||||||||
125635181 | 12563518 | 3 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | UNK | 0 | TABLET | |||||||||
125635181 | 12563518 | 4 | SS | CORTISONE ACETATE. | CORTISONE ACETATE | 1 | Unknown | 25 MG, UNK | 0 | 25 | MG | TABLET | |||||||
125635181 | 12563518 | 5 | SS | FOLIC ACID. | FOLIC ACID | 1 | Unknown | 1 MG, UNK | 0 | 1 | MG | TABLET | |||||||
125635181 | 12563518 | 6 | SS | FOSAMAX | ALENDRONATE SODIUM | 1 | Unknown | UNK | 0 | TABLET | |||||||||
125635181 | 12563518 | 7 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | UNK | 0 | ||||||||||
125635181 | 12563518 | 8 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | UNK | 0 | ||||||||||
125635181 | 12563518 | 9 | SS | ORENCIA | ABATACEPT | 1 | Unknown | UNK | 0 | ||||||||||
125635181 | 12563518 | 10 | SS | PHTHALYLSULFATHIAZOLE | PHTHALYLSULFATHIAZOLE | 1 | Unknown | UNK | 0 | ||||||||||
125635181 | 12563518 | 11 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | UNK | 0 | TABLET | |||||||||
125635181 | 12563518 | 12 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | 0 | ||||||||||
125635181 | 12563518 | 13 | SS | REACTINE | CETIRIZINE HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
125635181 | 12563518 | 14 | SS | REMICADE | INFLIXIMAB | 1 | Unknown | UNK | 0 | ||||||||||
125635181 | 12563518 | 15 | SS | RITUXAN | RITUXIMAB | 1 | Unknown | UNK | 0 | ||||||||||
125635181 | 12563518 | 16 | SS | SIMPONI | GOLIMUMAB | 1 | Unknown | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125635181 | 12563518 | 1 | Rheumatoid arthritis |
125635181 | 12563518 | 2 | Rheumatoid arthritis |
125635181 | 12563518 | 3 | Rheumatoid arthritis |
125635181 | 12563518 | 4 | Rheumatoid arthritis |
125635181 | 12563518 | 5 | Rheumatoid arthritis |
125635181 | 12563518 | 6 | Product used for unknown indication |
125635181 | 12563518 | 7 | Rheumatoid arthritis |
125635181 | 12563518 | 8 | Product used for unknown indication |
125635181 | 12563518 | 9 | Rheumatoid arthritis |
125635181 | 12563518 | 10 | Rheumatoid arthritis |
125635181 | 12563518 | 11 | Rheumatoid arthritis |
125635181 | 12563518 | 12 | Product used for unknown indication |
125635181 | 12563518 | 13 | Product used for unknown indication |
125635181 | 12563518 | 14 | Rheumatoid arthritis |
125635181 | 12563518 | 15 | Rheumatoid arthritis |
125635181 | 12563518 | 16 | Rheumatoid arthritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125635181 | 12563518 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125635181 | 12563518 | Abdominal discomfort | |
125635181 | 12563518 | Alopecia | |
125635181 | 12563518 | Fatigue | |
125635181 | 12563518 | Glossodynia | |
125635181 | 12563518 | Pain | |
125635181 | 12563518 | Pemphigus | |
125635181 | 12563518 | Swelling | |
125635181 | 12563518 | Systemic lupus erythematosus |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |